Citations

AbstractThe scope of conditions managed by embolization, which was initially used for the treatment of hemorrhage and vascular malformations, is constantly expanding. Apart from oncologic indications, embolization is used to treat a wide range of benign pathology, including uterine fibroids and benign prostatic hyperplasia. While various particulate embolic agents are successfully used for benign embolization, there is growing evidence that unique properties of these may result in different outcomes. This article reviews available evidence comparing various particles used for uterine fibroid embolization and prostate artery embolization. In addition, we provide an overview of periprocedural pharmacology and protocols facilitating same-day discharge for these interventions.

AbstractBackgroundDeep artificial neural networks such as convolutional neural networks (CNNs) have been shown to be effective models for reducing noise in CT images while preserving anatomic details. A practical bottleneck for developing CNN‐based denoising models is the procurement of training data consisting of paired examples of high‐noise and low‐noise CT images. Obtaining these paired data are not practical in a clinical setting where the raw projection data is not available. This work outlines a technique to optimize CNN denoising models using methods that are available in a routine clinical setting.PurposeTo demonstrate a phantom‐based training framework for CNN noise reduction that can be efficiently implemented on any CT scanner.MethodsThe phantom‐based training framework uses supervised learning in which training data are synthesized using an image‐based noise insertion technique. Ten patient image series were used for training and validation (9:1) and noise‐only images obtained from anthropomorphic phantom scans. Phantom noise‐only images were superimposed on patient images to imitate low‐dose CT images for use in training. A modified U‐Net architecture was used with mean‐squared‐error and feature reconstruction loss. The training framework was tested for clinically indicated whole‐body‐low‐dose CT images, as well as routine abdomen‐pelvis exams for which projection data was unavailable. Performance was assessed based on root‐mean‐square error, structural similarity, line profiles, and visual assessment.ResultsWhen the CNN was tested on five reserved quarter‐dose whole‐body‐low‐dose CT images, noise was reduced by 75%, root‐mean‐square‐error reduced by 34%, and structural similarity increased by 60%. Visual analysis and line profiles indicated that the method significantly reduced noise while maintaining spatial resolution of anatomic features.ConclusionThe proposed phantom‐based training framework demonstrated strong noise reduction while preserving spatial detail. Because this method is based within the image domain, it can be easily implemented without access to projection data.

AbstractLoss of consciousness is a hallmark of many epileptic seizures and carries risks of serious injury and sudden death. While cortical sleep-like activities accompany loss of consciousness during focal impaired awareness seizures, the mechanisms of loss of consciousness during focal to bilateral tonic-clonic seizures remain unclear. Quantifying differences in markers of cortical activation and ictal recruitment between focal impaired awareness and focal to bilateral tonic-clonic seizures may also help us to understand their different consequences for clinical outcomes and to optimize neuromodulation therapies.We quantified clinical signs of loss of consciousness and intracranial EEG activity during 129 focal impaired awareness and 50 focal to bilateral tonic-clonic from 41 patients. We characterized intracranial EEG changes both in the seizure onset zone and in areas remote from the seizure onset zone with a total of 3386 electrodes distributed across brain areas. First, we compared the dynamics of intracranial EEG sleep-like activities: slow-wave activity (1–4 Hz) and beta/delta ratio (a validated marker of cortical activation) during focal impaired awareness versus focal to bilateral tonic-clonic. Second, we quantified differences between focal to bilateral tonic-clonic and focal impaired awareness for a marker validated to detect ictal cross-frequency coupling: phase-locked high gamma (high-gamma phased-locked to low frequencies) and a marker of ictal recruitment: the epileptogenicity index. Third, we assessed changes in intracranial EEG activity preceding and accompanying behavioural generalization onset and their correlation with electromyogram channels. In addition, we analysed human cortical multi-unit activity recorded with Utah arrays during three focal to bilateral tonic-clonic seizures.Compared to focal impaired awareness, focal to bilateral tonic-clonic seizures were characterized by deeper loss of consciousness, even before generalization occurred. Unlike during focal impaired awareness, early loss of consciousness before generalization was accompanied by paradoxical decreases in slow-wave activity and by increases in high-gamma activity in parieto-occipital and temporal cortex. After generalization, when all patients displayed loss of consciousness, stronger increases in slow-wave activity were observed in parieto-occipital cortex, while more widespread increases in cortical activation (beta/delta ratio), ictal cross-frequency coupling (phase-locked high gamma) and ictal recruitment (epileptogenicity index). Behavioural generalization coincided with a whole-brain increase in high-gamma activity, which was especially synchronous in deep sources and could not be explained by EMG. Similarly, multi-unit activity analysis of focal to bilateral tonic-clonic revealed sustained increases in cortical firing rates during and after generalization onset in areas remote from the seizure onset zone.Overall, these results indicate that unlike during focal impaired awareness, the neural signatures of loss of consciousness during focal to bilateral tonic-clonic consist of paradoxical increases in cortical activation and neuronal firing found most consistently in posterior brain regions. These findings suggest differences in the mechanisms of ictal loss of consciousness between focal impaired awareness and focal to bilateral tonic-clonic and may account for the more negative prognostic consequences of focal to bilateral tonic-clonic.

Purpose: The electronic Medical Records and Genomics (eMERGE) Phase III study was undertaken to assess clinical utility of returning medically actionable genomic screening results. We assessed pediatric clinical outcomes following return of pathogenic/likely pathogenic (P/LP) variants in autosomal dominant conditions with available effective interventions. Methods: The two eMERGE III pediatric sites collected outcome data and assessed changes in medical management at 6 and 12 months. Results: We returned P/LP results to 29 participants with outcome data. For 23 of the 29 participants, the P/LP results were previously unknown. Five of the 23 participants were already followed for conditions related to the P/LP variant. Of those receiving novel results and not being followed for the condition related to the P/LP result (n = 18), 14 (77.8%) had a change in healthcare after return of results (RoR). Following RoR, cascade testing of family members occurred for 10 of 23 (43.5%). Conclusions: The most common outcomes post-RoR included imaging/laboratory testing and health behavior recommendations. A change in healthcare was documented in 77.8% of those receiving results by 6 months. Our findings demonstrate how return of genomic screening results impacts healthcare in pediatric populations.

ImportanceCytokine storm due to COVID-19 can cause high morbidity and mortality and may be more common in patients with cancer treated with immunotherapy (IO) due to immune system activation.ObjectiveTo determine the association of baseline immunosuppression and/or IO-based therapies with COVID-19 severity and cytokine storm in patients with cancer.Design, Setting, and ParticipantsThis registry-based retrospective cohort study included 12 046 patients reported to the COVID-19 and Cancer Consortium (CCC19) registry from March 2020 to May 2022. The CCC19 registry is a centralized international multi-institutional registry of patients with COVID-19 with a current or past diagnosis of cancer. Records analyzed included patients with active or previous cancer who had a laboratory-confirmed infection with SARS-CoV-2 by polymerase chain reaction and/or serologic findings.ExposuresImmunosuppression due to therapy; systemic anticancer therapy (IO or non-IO).Main Outcomes and MeasuresThe primary outcome was a 5-level ordinal scale of COVID-19 severity: no complications; hospitalized without requiring oxygen; hospitalized and required oxygen; intensive care unit admission and/or mechanical ventilation; death. The secondary outcome was the occurrence of cytokine storm.ResultsThe median age of the entire cohort was 65 years (interquartile range [IQR], 54-74) years and 6359 patients were female (52.8%) and 6598 (54.8%) were non-Hispanic White. A total of 599 (5.0%) patients received IO, whereas 4327 (35.9%) received non-IO systemic anticancer therapies, and 7120 (59.1%) did not receive any antineoplastic regimen within 3 months prior to COVID-19 diagnosis. Although no difference in COVID-19 severity and cytokine storm was found in the IO group compared with the untreated group in the total cohort (adjusted odds ratio [aOR], 0.80; 95% CI, 0.56-1.13, and aOR, 0.89; 95% CI, 0.41-1.93, respectively), patients with baseline immunosuppression treated with IO (vs untreated) had worse COVID-19 severity and cytokine storm (aOR, 3.33; 95% CI, 1.38-8.01, and aOR, 4.41; 95% CI, 1.71-11.38, respectively). Patients with immunosuppression receiving non-IO therapies (vs untreated) also had worse COVID-19 severity (aOR, 1.79; 95% CI, 1.36-2.35) and cytokine storm (aOR, 2.32; 95% CI, 1.42-3.79).Conclusions and RelevanceThis cohort study found that in patients with cancer and COVID-19, administration of systemic anticancer therapies, especially IO, in the context of baseline immunosuppression was associated with severe clinical outcomes and the development of cytokine storm.Trial RegistrationClinicalTrials.gov Identifier: NCT04354701

In the original publication [...]

AbstractBackgroundCurrent CT quality control (QC) for low‐contrast detectability relies on visual inspection and measurement of contrast‐to‐noise ratio (CNR). However, CNR numbers become unreliable when it comes to nonlinear methods, such as iterative reconstruction (IR) and deep‐learning‐based techniques. Image quality metrics using channelized Hotelling observer (CHO) have been validated to be well correlated with human observer performance on phantom‐based and patient‐based tasks, but it has not been widely used in routine CT QC mainly because the CHO calculation typically requires a large number of repeated scans in order to provide accurate and precise estimate of index of detectability (d′).PurposeThe main goal of this work is to optimize channel filters and other CHO parameters and accurately estimate the low‐contrast detectability with minimum number of repeated scans for the widely used American College of Radiology (ACR) CT accreditation phantom so that it can become practically feasible for routine CT QC tests.MethodsTo provide a converged d′ value, an ACR phantom was repeatedly scanned 100 times at three dose levels (24, 12, and 6 mGy). Images were reconstructed with two kernels (FBP Br44 and IR Br44‐3). d′ as a function of number of repeated scans was determined for different number of background regions of interest (ROIs), different number of low‐contrast objects, different number of slices per each object, and different channel filter options. A reference d′ was established using the optimized CHO setting, and the bias of d′ was quantified using the d′ calculated from all 100 repeated scans. The variation of d′ at each condition was estimated using a resampling method combining random subsampling among 100 repeated scans and bootstrapping of the ensembles of signal and background ROIs.ResultsOptimized parameters in CHO calculation were determined: two background ROIs per object, four objects per low‐contrast object size, nine non‐overlapping slices per object, and a 4‐channel Gabor filter. The bias and uncertainty were estimated at different numbers of repeated scans using these parameters. When only one single scan was used in the CHO calculation, the bias of d′ was below 6.2% and the uncertainty 15.6‐19.6% for the 6, 5, and 4 mm objects, while with three repeated scans the bias was below 2.0% and uncertainty 8.7‐10.9% for the three object sizes.ConclusionWith optimized parameter settings in CHO, efficient and accurate measurement of low‐contrast detectability on the commonly used ACR phantom becomes feasible, which could potentially lead to adoption of CHO‐based low‐contrast evaluation in routine QC tests.